A study on colon cancer also showed that phosphorylation of the EGFR and downstream signal activation is enhanced by DSG2, where downregulation of DSG2 decreases EGF-induced cell proliferation and suppresses in vivo xenograft tumor growth (92). The gene discussed is EGFR; the disease is colonic neoplasm.